I hope the most effective agents can be used in both laparoscopy and laparotomy, and that they will decrease the adhesion-formation rate by more than 50%. We need to find the magic bullet that can cover the entire pelvis—if not the entire abdomen.
Dr. DeCherney reports small holdings with Lifecore Biomedical and Johnson & Johnson. Drs. Hurd and Pagidas report no financial relationship with any companies whose products are mentioned in this article. Dr. Sanfilippo serves on the speaker’s bureau for Berlex, Ortho Pharmaceuticals, and Wyeth, and receives grant support from Eli Lilly and Wyeth.